Akebia Therapeutics Statistics
Total Valuation
AKBA has a market cap or net worth of $451.20 million. The enterprise value is $585.70 million.
Important Dates
The last earnings date was Thursday, March 13, 2025, before market open.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AKBA has 236.23 million shares outstanding. The number of shares has increased by 12.53% in one year.
Current Share Class | 236.23M |
Shares Outstanding | 236.23M |
Shares Change (YoY) | +12.53% |
Shares Change (QoQ) | +3.97% |
Owned by Insiders (%) | 2.43% |
Owned by Institutions (%) | 28.51% |
Float | 230.49M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.54 |
Forward PS | 2.40 |
PB Ratio | -9.13 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3.66 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.41
Current Ratio | 1.41 |
Quick Ratio | 1.07 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.54 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -12.49% |
Return on Invested Capital (ROIC) | -22.81% |
Return on Capital Employed (ROCE) | -33.06% |
Revenue Per Employee | $884,972 |
Profits Per Employee | -$383,481 |
Employee Count | 181 |
Asset Turnover | 0.69 |
Inventory Turnover | 1.64 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.51% in the last 52 weeks. The beta is 0.94, so AKBA's price volatility has been similar to the market average.
Beta (5Y) | 0.94 |
52-Week Price Change | -14.51% |
50-Day Moving Average | 2.08 |
200-Day Moving Average | 1.65 |
Relative Strength Index (RSI) | 46.07 |
Average Volume (20 Days) | 5,763,606 |
Short Selling Information
The latest short interest is 14.98 million, so 6.34% of the outstanding shares have been sold short.
Short Interest | 14.98M |
Short Previous Month | 14.45M |
Short % of Shares Out | 6.34% |
Short % of Float | 6.50% |
Short Ratio (days to cover) | 5.03 |
Income Statement
In the last 12 months, AKBA had revenue of $160.18 million and -$69.41 million in losses. Loss per share was -$0.33.
Revenue | 160.18M |
Gross Profit | 134.03M |
Operating Income | -46.21M |
Pretax Income | -40.44M |
Net Income | -69.41M |
EBITDA | -8.70M |
EBIT | -46.21M |
Loss Per Share | -$0.33 |
Full Income Statement Balance Sheet
The company has $51.87 million in cash and $188.73 million in debt, giving a net cash position of -$136.86 million or -$0.58 per share.
Cash & Cash Equivalents | 51.87M |
Total Debt | 188.73M |
Net Cash | -136.86M |
Net Cash Per Share | -$0.58 |
Equity (Book Value) | -49.19M |
Book Value Per Share | -0.22 |
Working Capital | 32.92M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$40.66 million and capital expenditures -$33,000, giving a free cash flow of -$40.69 million.
Operating Cash Flow | -40.66M |
Capital Expenditures | -33,000 |
Free Cash Flow | -40.69M |
FCF Per Share | -$0.17 |
Full Cash Flow Statement Margins
Gross margin is 83.68%, with operating and profit margins of -28.85% and -43.33%.
Gross Margin | 83.68% |
Operating Margin | -28.85% |
Pretax Margin | -43.33% |
Profit Margin | -43.33% |
EBITDA Margin | -5.43% |
EBIT Margin | -28.85% |
FCF Margin | n/a |
Dividends & Yields
AKBA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.53% |
Shareholder Yield | -12.53% |
Earnings Yield | -15.46% |
FCF Yield | -9.07% |
Analyst Forecast
The average price target for AKBA is $6.75, which is 253.40% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.75 |
Price Target Difference | 253.40% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 42.84% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AKBA has an Altman Z-Score of -9.75 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -9.75 |
Piotroski F-Score | 4 |